FOCUS-Biogen provides free Aduhelm as U.S. clinics await Medicare payment
August 30, 2021
By Deena Beasley
Reuters Aug 30 (Reuters) – Biogen Inc is providing its controversial and expensive new Alzheimer’s drug free of charge for some patients amid slow claim reviews by Medicare, according to sources familiar with the situation, including a doctor treating patients with the drug.
Read the source article at Netscape ISP Homepage
2021-08-30 11:00:58
